RECURSION PHARMACEUTICALS, INC. - Class A Stock (RXRX)
CUSIP: 75629V104
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Class A Stock
- Shares outstanding
- 525,302,736
- Total 13F shares
- 251,836,128
- Share change
- +40,762,649
- Total reported value
- $1,888,574,788
- Put/Call ratio
- 248%
- Price per share
- $7.50
- Number of holders
- 264
- Value change
- +$298,622,706
- Number of buys
- 174
- Number of sells
- 94
Quarterly Holders Quick Answers
What is CUSIP 75629V104?
CUSIP 75629V104 identifies RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 75629V104:
Top shareholders of RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BAILLIE GIFFORD & CO |
13F
|
Company |
—
mixed-class rows
|
257,067,477
mixed-class rows
|
$510,235,627 | — | 31 Mar 2024 | |
| ARK Investment Management LLC |
13F
|
Company |
—
mixed-class rows
|
214,194,469
mixed-class rows
|
$465,081,992 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
—
mixed-class rows
|
141,871,428
mixed-class rows
|
$305,660,926 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
—
mixed-class rows
|
85,183,127
mixed-class rows
|
$207,360,747 | — | 31 Mar 2024 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
—
mixed-class rows
|
66,227,851
mixed-class rows
|
$168,120,602 | — | 31 Mar 2024 | |
| Amova Asset Management Americas, Inc. |
13F
|
Company |
—
mixed-class rows
|
66,227,851
mixed-class rows
|
$167,913,346 | — | 31 Mar 2024 | |
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
37%
|
143,085,126
|
$165,978,746 | — | 31 Mar 2024 | |
| Lux Ventures IV, L.P. |
3/4/5
|
Former 10% Owner |
—
class O/S missing
|
13,021,519
|
$137,710,376 | — | 07 Dec 2021 | |
| Mubadala Investment Co PJSC |
3/4/5
13F
|
10%+ Owner · Company |
2.5%
from 13F
|
12,985,927
|
$137,333,970 | — | 02 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
—
mixed-class rows
|
36,937,850
mixed-class rows
|
$134,052,162 | — | 31 Mar 2024 | |
| Kinnevik AB (publ) |
13F
|
Company |
2%
|
10,405,668
|
$103,744,510 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
—
mixed-class rows
|
9,286,777
mixed-class rows
|
$92,360,939 | — | 31 Mar 2024 | |
| MIC Capital Management UK LLP |
13F
|
Company |
1.6%
|
8,451,758
|
$84,264,027 | — | 31 Mar 2024 | |
| Anchorage Capital Group, L.L.C. |
13F
|
Company |
18%
|
69,854,593
|
$81,031,328 | — | 31 Mar 2024 | |
| NVIDIA CORP |
13F
|
Company |
1.5%
|
7,706,363
|
$76,832,439 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
—
mixed-class rows
|
51,035,038
mixed-class rows
|
$76,501,525 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
—
mixed-class rows
|
25,341,730
mixed-class rows
|
$59,811,350 | — | 31 Mar 2024 | |
| Data Collective IV GP, LLC |
13F
|
Company |
1.1%
|
5,941,120
|
$59,232,966 | — | 31 Mar 2024 | |
| NORGES BANK |
13F
|
Company |
—
mixed-class rows
|
18,653,532
mixed-class rows
|
$49,588,192 | — | 31 Mar 2024 | |
| Zachary Bogue |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
3,736,341
|
$39,514,048 | — | 03 Jul 2023 | |
| DCVC Opportunity Fund II GP, LLC |
13F
|
Company |
0.75%
|
3,951,141
|
$39,392,876 | — | 31 Mar 2024 | |
| Lingotto Investment Management LLP |
13F
|
Company |
—
mixed-class rows
|
12,186,378
mixed-class rows
|
$33,298,627 | — | 31 Mar 2024 | |
| SB INVESTMENT ADVISERS (UK) LTD |
13F
|
Company |
6.4%
|
24,429,191
|
$28,337,862 | — | 31 Mar 2024 | |
| GLENVIEW CAPITAL MANAGEMENT, LLC |
13F
|
Company |
6.3%
|
24,000,000
|
$27,840,000 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
—
mixed-class rows
|
9,105,584
mixed-class rows
|
$21,249,113 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.4%
|
2,095,000
|
$20,887,150 | — | 31 Mar 2024 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
—
mixed-class rows
|
3,082,903
mixed-class rows
|
$20,640,873 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
—
mixed-class rows
|
4,820,146
mixed-class rows
|
$20,594,042 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
—
mixed-class rows
|
7,253,285
mixed-class rows
|
$19,749,550 | — | 31 Mar 2024 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
0.34%
|
1,800,469
|
$17,950,676 | — | 31 Mar 2024 | |
| Legal & General Group Plc |
13F
|
Company |
—
mixed-class rows
|
11,589,547
mixed-class rows
|
$14,884,648 | — | 31 Mar 2024 | |
| Vestmark Advisory Solutions, Inc. |
13F
|
Company |
—
mixed-class rows
|
5,968,566
mixed-class rows
|
$14,852,704 | — | 31 Mar 2024 | |
| MIC Capital Partners (Public) Parallel Cayman, LP |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,388,889
|
$14,688,335 | — | 01 Nov 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
—
mixed-class rows
|
4,719,769
mixed-class rows
|
$13,243,675 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
—
mixed-class rows
|
5,111,975
mixed-class rows
|
$12,950,598 | — | 31 Mar 2024 | |
| Erste Asset Management GmbH |
13F
|
Company |
—
mixed-class rows
|
10,833,500
mixed-class rows
|
$12,868,695 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
—
mixed-class rows
|
10,586,178
mixed-class rows
|
$12,377,555 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
—
mixed-class rows
|
1,684,255
mixed-class rows
|
$11,487,081 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
—
mixed-class rows
|
3,061,338
mixed-class rows
|
$11,453,898 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
—
mixed-class rows
|
3,407,561
mixed-class rows
|
$11,299,183 | — | 31 Mar 2024 | |
| Liontrust Investment Partners LLP |
13F
|
Company |
—
mixed-class rows
|
3,650,000
mixed-class rows
|
$10,841,500 | — | 31 Mar 2024 | |
| Comprehensive Financial Management LLC |
13F
|
Company |
—
mixed-class rows
|
1,648,197
mixed-class rows
|
$10,210,003 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
—
mixed-class rows
|
2,170,550
mixed-class rows
|
$9,576,296 | — | 31 Mar 2024 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
—
mixed-class rows
|
1,293,861
mixed-class rows
|
$9,343,885 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
—
mixed-class rows
|
1,009,632
mixed-class rows
|
$9,069,162 | — | 31 Mar 2024 | |
| Laurion Capital Management LP |
13F
|
Company |
0.17%
|
907,616
|
$9,048,932 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
—
mixed-class rows
|
4,869,432
mixed-class rows
|
$8,647,235 | — | 31 Mar 2024 | |
| WELCH & FORBES LLC |
13F
|
Company |
1.8%
|
7,000,000
|
$8,120,000 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
—
mixed-class rows
|
1,283,028
mixed-class rows
|
$7,412,430 | — | 31 Mar 2024 | |
| Mitsubishi UFJ Trust & Banking Corp |
13F
|
Company |
—
mixed-class rows
|
3,943,070
mixed-class rows
|
$6,955,833 | — | 31 Mar 2024 |
Institutional Holders of RECURSION PHARMACEUTICALS, INC. - Class A Stock (RXRX) as of Q2 2024
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.